Skip to content

Development of New Technology Combining DBT and iTBS for Treating Adolescent Depression with NSSI

Development of New Technology Combining DBT and iTBS for Treating Adolescent Depression with NSSI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119563
Enrollment
Unknown
Registered
2026-02-28
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression with non-suicidal self-injury (NSSI)

Interventions

DBT-only group:Dialectical Behavior Therapy(DBT)
iTBS-only group:iTBS therapeutic protocol (the latter being a high-frequency rTMS modality)
Combined (DBT+iTBS) group:The combined DBT and iTBS therapeutic protocol (the latter being a high-frequency rTMS modality).

Sponsors

The Second People's Hospital of Taizhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Participation is voluntary. For patients under the age of 18, informed consent must be obtained from a parent or guardian, who must sign the informed consent form. 2. Meet the diagnostic criteria for Major Depressive Disorder (MDD) as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), and present without psychotic features. 3. Participants must have a history of or currently exhibit non-suicidal self-injury (NSSI) behavior directed toward the body surface, capable of inducing bleeding, bruising, or pain, and meet the proposed diagnostic criteria for Nonsuicidal Self-Injury as outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). 4. A Patient Health Questionnaire-9 (PHQ-9) score of <=14. 5. A Generalized Anxiety Disorder-7 (GAD-7) score of <=14. 6. Aged between 12 and 18 years old.

Exclusion criteria

Exclusion criteria: 1. Exclusion of patients with epilepsy or acute cerebrovascular accident. 2. Exclude patients with severe somatic diseases—such as neurological, cardiac, hepatic, renal, endocrine, or hematological disorders—or any other conditions that may interfere with the trial assessment. 3. Exclude patients with organic mental disorders, intellectual disability, or bipolar disorder. 4. Exclude patients with alcohol or drug dependence. 5. Exclude patients with suicidal ideation or behavior. 6. Exclude patients who have received modified electroconvulsive therapy (MECT) within the past 3 months. 7. Exclude subjects with absolute contraindications to rTMS, such as the presence of metallic components in close contact with the coil (e.g., cochlear implants, implanted medication pumps, aneurysm clips).

Design outcomes

Primary

MeasureTime frame
brain derived neurotrophic factor,BDNF;brief version of the difficulties in emotion regulation scale,DERS-16;7-item Generalized Anxiety Disorder Scale , GAD-7;Ottawa self-injury inventory,OSI;Patient Health Questionnaire-9, PHQ-9;simplified coping style question-naire,SCSQ;Beck Scale for Suicide Ideation- Chinese Version, BSI-CV;

Countries

China

Contacts

Public ContactXiaojing Wang

The Second People's Hospital Of Taizhou

493720025@qq.com+86 576 83979722

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026